Epix/Schering Vascular Imaging Agent Approval Delayed, Needs New Trial
This article was originally published in The Gray Sheet
Executive Summary
Epix' MS-325 magnetic resonance angiography vascular imaging agent will need additional studies prior to approval due to a lack of standardization in non-contrast comparator scans